|
Veterinary Research Forum، جلد ۱۶، شماره ۱، صفحات ۱-۱۰
|
|
|
عنوان فارسی |
|
|
چکیده فارسی مقاله |
|
|
کلیدواژههای فارسی مقاله |
|
|
عنوان انگلیسی |
N-acetylcysteine enhances bone marrow activity in treating pancytopenia induced by canine hemoprotozoan diseases |
|
چکیده انگلیسی مقاله |
Canine hemoprotozoan diseases viz. ehrlichiosis and babesiosis are mostly associated with critical anemia and thrombocytopenia with pancytopenic changes, leading to multi-organ failure. For faster recovery of patients with complicated hemoprotozoan diseases, whole blood transfusion or bone marrow stimulating agents to produce more red blood cells (RBCs) and platelets might be helpful. Unfortunately, canine specific transfusion procedures are expensive and even not available in many developing countries. Development of alternate therapeutic modality by bone marrow stimulation to augment the production of RBCs and platelets and thus, to treat the critical pancytopenic patients is and urgent necessity. N-acetylcysteine (NAC), acts as a precursor of reduced glutathione and increases the production of bone marrow B cells. It also improves viability and self-renewal capacity of stem cells and thus, boosts hematopoietic differentiation by protecting induced pluripotent stem cells. This study envisaged to develop alternate therapeutic approach to combat pancytopenia secondary to canine hemoprotozoan diseases. Bone marrow mediated aplastic pancytopenia was induced experimentally by administration of cyclophosphamide in rats. Bone marrow stimulating property of NAC was compared with desmopressin, another bone marrow stimulator, which revealed better in terms of hematobiochemical and histopathological changes. Results of rat model study were extrapolated in clinical canine hemoprotozoan cases having pancytopenia. Dogs treated with hemoprotozoan disease specific therapy along with NAC rendered favorable changes by haltering the progression of critical anemia and thrombocytopenia. Study revealed that supplementation of NAC along with canine hemoprotozoan specific therapy is beneficial to alleviate pancytopenia. |
|
کلیدواژههای انگلیسی مقاله |
Anemia,Anti-oxidant,Cyclophosphamide,Hematopoiesis |
|
نویسندگان مقاله |
Narayani Yadav | PhD Scholar, Division of Medicine, Indian Council of Agricultural Research-Indian Veterinary Research Institute, Bareilly, India
Debabrata Mondal | Division of Medicine, Indian Council of Agricultural Research-Indian Veterinary Research Institute, Bareilly, India
Raguvaran Raja | Division of Medicine, Indian Council of Agricultural Research-Indian Veterinary Research Institute, Bareilly, India
Ensha Lomiya MA | MVSc Scholar, Division of Medicine, Indian Council of Agricultural Research-Indian Veterinary Research Institute, Bareilly, India
Karam Pal Singh | Center for Animal Disease Research and Diagnosis, Indian Council of Agricultural Research-Indian Veterinary Research Institute, Bareilly, India
Dushyant Kumar Sharma | Indian Council of Agricultural Research-Central Sheep and Wool Research Institute, Malpura, India
Arvind Kumar Das | Bihar Veterinary College, Patna, India
|
|
نشانی اینترنتی |
https://vrf.iranjournals.ir/article_719470_22bede1993f3dd65cb44aa56e577115f.pdf |
فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
کد مقاله (doi) |
|
زبان مقاله منتشر شده |
en |
موضوعات مقاله منتشر شده |
|
نوع مقاله منتشر شده |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|